TRANSCRIPTIONAL REPRESSION AND P53 DEPENDENT APOPTOSIS

转录抑制和 P53 依赖性细胞凋亡

基本信息

  • 批准号:
    6350357
  • 负责人:
  • 金额:
    $ 25.11万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1999
  • 资助国家:
    美国
  • 起止时间:
    1999-04-01 至 2004-01-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION: (adapted verbatim from the investigator's abstract) The p53 tumor suppressor gene continues to hold distinction as the most frequently mutated gene in human cancer. The powerful selection for mutation of p53 in cancer is believed to result from its ability to induce programmed cell death (apoptosis). Evidence from several groups indicates that apoptosis induction by p53 does not rely on its best- characterized activity, transcriptional activation. This proposal seeks to characterize a new activity of p53, sequence-specific transcriptional repression. Wild type (wt) p53 induction in normal and tumor cells leads to transcriptional repression of Map4, which encodes a ubiquitously- expressed microtubule-polymerizing protein. Overexpression of Map4 in cells undergoing p53-dependent apoptosis delays the appearance of dying cells, verifying the importance of this process to apoptosis. In stably- transfected cells, the Map4 promoter can confer negative regulation by p53 to a heterologous gene. A fragment of this promoter can interact with wt but not mutant p53 protein in cell extracts. Recent data indicate that in addition to Map4, p53 represses other genes encoding components of microtubules. Elucidation of the mechanism of transcriptional repression by p53 is likely to be a critical step toward understanding tumor suppression by this protein. Understanding other targets genes of p53-mediated repression will also be important. This proposal seeks to achieve these goals.
描述:(从研究者的摘要逐字改编)p53

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Maureen E. Murphy其他文献

RETRACTED ARTICLE: IspH inhibitors kill Gram-negative bacteria and mobilize immune clearance
撤回文章:IspH 抑制剂杀死革兰氏阴性菌并动员免疫清除
  • DOI:
    10.1038/s41586-020-03074-x
  • 发表时间:
    2020-12-23
  • 期刊:
  • 影响因子:
    48.500
  • 作者:
    Kumar Sachin Singh;Rishabh Sharma;Poli Adi Narayana Reddy;Prashanthi Vonteddu;Madeline Good;Anjana Sundarrajan;Hyeree Choi;Kar Muthumani;Andrew Kossenkov;Aaron R. Goldman;Hsin-Yao Tang;Maxim Totrov;Joel Cassel;Maureen E. Murphy;Rajasekharan Somasundaram;Meenhard Herlyn;Joseph M. Salvino;Farokh Dotiwala
  • 通讯作者:
    Farokh Dotiwala
Kaposi’s sarcoma-associated herpesvirus induces mitochondrial fission to evade host immune responses and promote viral production
卡波西肉瘤相关疱疹病毒诱导线粒体分裂以逃避宿主免疫反应并促进病毒产生
  • DOI:
    10.1038/s41564-025-02018-3
  • 发表时间:
    2025-05-22
  • 期刊:
  • 影响因子:
    19.400
  • 作者:
    Qing Zhu;Robert McElroy;Janvhi Suresh Machhar;Joel Cassel;Zihan Zheng;Behzad Mansoori;Hongrui Guo;Sen Guo;Christian Pangilinan;Jinghui Liang;Dongliang Shen;Lu Zhang;Qin Liu;Andrew V. Kossenkov;Dario C. Altieri;Paul M. Lieberman;Shou-Jiang Gao;Pinghui Feng;Maureen E. Murphy;Jikui Song;Joseph M. Salvino;Qiming Liang;Jae U. Jung;Chengyu Liang
  • 通讯作者:
    Chengyu Liang
Mitochondrial p53 activates Bak and causes disruption of a Bak–Mcl1 complex
线粒体 p53 激活 Bak 并导致 Bak-Mcl1 复合物的破坏
  • DOI:
    10.1038/ncb1123
  • 发表时间:
    2004-04-11
  • 期刊:
  • 影响因子:
    19.100
  • 作者:
    J. I-Ju Leu;Patrick Dumont;Michael Hafey;Maureen E. Murphy;Donna L. George
  • 通讯作者:
    Donna L. George

Maureen E. Murphy的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Maureen E. Murphy', 18)}}的其他基金

Functional Analysis of p53 Polymorphic Variants - Diversity Supplement
p53 多态性变体的功能分析 - Diversity Supplement
  • 批准号:
    10818904
  • 财政年份:
    2023
  • 资助金额:
    $ 25.11万
  • 项目类别:
The genetics of tumor suppression by p53
p53 抑制肿瘤的遗传学
  • 批准号:
    10636305
  • 财政年份:
    2023
  • 资助金额:
    $ 25.11万
  • 项目类别:
Purchase of a SARRP 200 Platform for Irradiation
购买 SARRP 200 辐照平台
  • 批准号:
    10430904
  • 财政年份:
    2022
  • 资助金额:
    $ 25.11万
  • 项目类别:
The impact of coding region variants on mutant p53 biology
编码区变异对突变 p53 生物学的影响
  • 批准号:
    10304135
  • 财政年份:
    2019
  • 资助金额:
    $ 25.11万
  • 项目类别:
The impact of coding region variants on mutant p53 biology
编码区变异对突变 p53 生物学的影响
  • 批准号:
    10523512
  • 财政年份:
    2019
  • 资助金额:
    $ 25.11万
  • 项目类别:
The impact of coding region variants on mutant p53 biology
编码区变异对突变 p53 生物学的影响
  • 批准号:
    9914543
  • 财政年份:
    2019
  • 资助金额:
    $ 25.11万
  • 项目类别:
The impact of coding region variants on mutant p53 biology
编码区变异对突变 p53 生物学的影响
  • 批准号:
    10063505
  • 财政年份:
    2019
  • 资助金额:
    $ 25.11万
  • 项目类别:
p53 Variants in Cancer Risk and Therapy
p53 癌症风险和治疗的变异
  • 批准号:
    9188088
  • 财政年份:
    2015
  • 资助金额:
    $ 25.11万
  • 项目类别:
p53 Variants in Cancer Risk and Therapy
p53 癌症风险和治疗的变异
  • 批准号:
    9007017
  • 财政年份:
    2015
  • 资助金额:
    $ 25.11万
  • 项目类别:
p53 Variants in Cancer Risk and Therapy
p53 癌症风险和治疗的变异
  • 批准号:
    9377535
  • 财政年份:
    2015
  • 资助金额:
    $ 25.11万
  • 项目类别:

相似海外基金

Establishment of a Mouse NK Cell Line for Analyzing Tumor Infiltration Processes and Developing a Preclinical Model for Cancer Immunotherapy.
建立小鼠 NK 细胞系,用于分析肿瘤浸润过程并开发癌症免疫治疗的临床前模型。
  • 批准号:
    23K06731
  • 财政年份:
    2023
  • 资助金额:
    $ 25.11万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Proof of usefulness of PDX derived cell line
PDX 衍生细胞系的有用性证明
  • 批准号:
    23K06616
  • 财政年份:
    2023
  • 资助金额:
    $ 25.11万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A novel producer cell line for more efficient manufacturing of viral vector systems
用于更有效地制造病毒载体系统的新型生产细胞系
  • 批准号:
    10597799
  • 财政年份:
    2023
  • 资助金额:
    $ 25.11万
  • 项目类别:
Genestorian: a web application to document and trace genetic modifications in model organism and cell line collections.
Genestorian:一个网络应用程序,用于记录和追踪模型生物和细胞系集合中的遗传修饰。
  • 批准号:
    EP/Y024591/1
  • 财政年份:
    2023
  • 资助金额:
    $ 25.11万
  • 项目类别:
    Fellowship
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
  • 批准号:
    10672364
  • 财政年份:
    2022
  • 资助金额:
    $ 25.11万
  • 项目类别:
Developing a stable cell line expressing recombinant sclerostin
开发表达重组硬化素的稳定细胞系
  • 批准号:
    10385037
  • 财政年份:
    2022
  • 资助金额:
    $ 25.11万
  • 项目类别:
Development of Natural Killer (NK) Cell Line-Derived Extracellular Vesicles as a New Treatment for Cancer
开发自然杀伤 (NK) 细胞系衍生的细胞外囊泡作为癌症的新治疗方法
  • 批准号:
    10383462
  • 财政年份:
    2022
  • 资助金额:
    $ 25.11万
  • 项目类别:
A cell culture management platform to improve biomedical reproducibility by combining cell line tracking, low-cost genetic analysis, and riskassessment
细胞培养管理平台,通过结合细胞系追踪、低成本遗传分析和风险评估来提高生物医学重现性
  • 批准号:
    10483063
  • 财政年份:
    2022
  • 资助金额:
    $ 25.11万
  • 项目类别:
Modulating expression of candidate genes to improve lentiviral vector production in stable cell line
调节候选基因的表达以提高稳定细胞系中慢病毒载体的产量
  • 批准号:
    2752732
  • 财政年份:
    2022
  • 资助金额:
    $ 25.11万
  • 项目类别:
    Studentship
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
  • 批准号:
    10546865
  • 财政年份:
    2022
  • 资助金额:
    $ 25.11万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了